Sciomics GmbH

Sciomics supports and speeds up Protein Biomarker Research and Discovery Programmes for Precision Medicine and Companion Diagnostic applications. Based on our unique antibody microarray platform we reduce costs and attrition rates for biomarker identification and verification projects and provide comprehensive protein expression level analysis.

Based on our proprietary system for highly-parallel protein analyses, we established a broad internal biomarker development pipeline for oncological indications as well as kidney injury. These newly developed biomarker signatures enable a precise diagnosis and patient stratification leading to a precise therapy adapted to the individual patient needs.

  • Mitarbeiterzahl

    10
  • Gegründet

    2013
  • Aktualisiert am

    15.03.2017